SCRT1: A Potential Drug Target and Biomarker (G83482)

Target Name: SCRT1

NCBI ID: G83482

SCRT1

SCRT1: A Potential Drug Target and Biomarker

SCRT1 (short for Secure Chemical Releasing Transport-1) is a gene that has been identified as a potential drug target and biomarker for various diseases, including cancer. SCRT1 is a transmembrane protein that is expressed in various tissues and cells in the body, including the brain, pancreas, and gastrointestinal tract.

The potential drug target for SCRT1 is its role in the transport of various molecules, including drugs, toxins, and other substances across cell membranes. SCRT1 has been shown to play a crucial role in the production and release of neurotransmitters, such as dopamine and serotonin, which are involved in various brain functions.

Additionally, SCRT1 has been linked to the transport of other molecules that are involved in diseases, such as cancer. For example, studies have shown that high levels of SCRT1 have been observed in various types of cancer, and that inhibiting SCRT1 may be a potential strategy for cancer treatment.

Another potential benefit of targeting SCRT1 is its potential as a biomarker. The development of new diagnostic tests and biomarkers for diseases is a major area of research and development in the field of medicine. SCRT1 has the potential to serve as a biomarker for various diseases, including cancer, due to its expression in different tissues and its involvement in the transport of molecules that are involved in disease.

In conclusion, SCRT1 is a gene that has the potential to be a drug target and biomarker for various diseases. Further research is needed to fully understand its role in the body and its potential as a therapeutic target. If its potential as a drug target and biomarker is confirmed, SCRT1 may be a valuable tool in the development of new treatments for a variety of diseases.

Protein Name: Scratch Family Transcriptional Repressor 1

Functions: Transcriptional repressor that binds E-box motif CAGGTG. Can modulate the action of basic helix-loop-helix (bHLH) transcription factors, critical for neuronal differentiation

The "SCRT1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SCRT1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets